期刊
FIBROGENESIS & TISSUE REPAIR
卷 8, 期 -, 页码 -出版社
BMC
DOI: 10.1186/s13069-015-0022-0
关键词
Human lung myofibroblast; Idiopathic pulmonary fibrosis; Potassium channel KCa3.1
类别
资金
- Dunhill Medical Trust [R270/1112]
- National Institute for Health Research Leicester Respiratory Biomedical Research Unit
- National Institute of Health [RO1 GM076063]
- NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076063] Funding Source: NIH RePORTER
- The Dunhill Medical Trust [R270/1112] Funding Source: researchfish
Background: Idiopathic pulmonary fibrosis (IPF) is a common and invariably lethal interstitial lung disease with poorly effective therapy. Blockade of the K+ channel K(Ca)3.1 reduces constitutive alpha-SMA and Smad2/3 nuclear translocation in IPF-derived human lung myofibroblasts (HLMFs), and inhibits several transforming growth factor beta 1 (TGF beta 1)-dependent cell processes. We hypothesized that K(Ca)3.1-dependent cell processes also regulate the TGF beta 1-dependent Smad2/3 signalling pathway in HLMFs. HLMFs obtained from non-fibrotic controls (NFC) and IPF lungs were grown in vitro and examined for alpha SMA expression by immunofluorescence, RT-PCR, and flow cytometry. Two specific and distinct K(Ca)3.1 blockers (TRAM-34 200 nM and ICA-17043 [Senicapoc] 100 nM) were used to determine their effects on TGF beta 1-dependent signalling. Expression of phosphorylated and total Smad2/3 following TGF beta 1 stimulation was determined by Western blot and Smad2/3 nuclear translocation by immunofluorescence. Results: K(Ca)3.1 block attenuated TGF beta 1-dependent Smad2/3 phosphorylation and nuclear translocation, and this was mimicked by lowering the extracellular Ca2+ concentration. K(Ca)3.1 block also inhibited Smad2/3-dependent gene transcription (alpha SMA, collagen type I), inhibited K(Ca)3.1 mRNA expression, and attenuated TGF beta 1-dependent alpha SMA protein expression. Conclusions: K(Ca)3.1 activity regulates TGF beta 1-dependent effects in NFC-and IPF-derived primary HLMFs through the regulation of the TGF beta 1/Smad signalling pathway, with promotion of downstream gene transcription and protein expression. K(Ca)3.1 blockers may offer a novel approach to treating IPF.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据